News
BriaCell Announces First Patient Dosed in Phase I/IIa Clinical Study...
www.finanznachrichten.de
WKN: A12F8U ISIN: CA10778Y1043 Ticker-Symbol: 8BT, Stuttgart | Farrah Dean Manager, Corporate Development
BriaCell Closes CEO Equity Investment
www.globenewswire.com
Ms. Farrah Dean Manager, Corporate Development Phone: · Facebook; Twitter; Linkedin; Share ...
BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical...
www.finanznachrichten.de
WKN: A12F8U ISIN: CA10778Y1043 Ticker-Symbol: 8BT, Stuttgart | | 20:21 Uhr Farrah Dean ...
BriaCell Announces Participation at the 21st Annual Global Investment...
www.einnews.com
Farrah Dean Manager, Corporate Development . Phone: Primary Logo. Powered by EIN News.
sortiert nach Relevanz / Datum